ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,827.04
      -1.54%
      US Tech 100
      20,287.60
      0.00%
      Dow Jones
      41,938.45
      -1.63%
      Brent Oil
      80.435
      -0.22%
      Bitcoin
      93,420.90
      -1.13%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Hutchmed (china) Limited (HCM) Quote

      Hutchmed (china) Limited

      Hutchmed (china) Limited (HCM)

      HUTCHMED China Limited
      Hitachi Construction Machinery Co Ltd
      249.00
      0.00
      ( 0.00% )
      Updated: 19:00:00
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      249.00
      Bid
      245.00
      Ask
      248.00
      Volume
      0.00
      0.00 Day's Range 0.00
      190.40 52 Week Range 353.00
      Market Cap
      2.17B
      Previous Close
      249.00
      Open
      -
      Last Trade
      (O)
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      63,107
      Shares Outstanding
      871,601,095
      Dividend Yield
      -
      PE Ratio
      0.00
      Earnings Per Share (EPS)
      -
      Revenue
      838M
      Net Profit
      100.78M

      About Hutchmed (china) Limited

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.hutch-med.com
      Headquarters
      Grand Cayman, Cym
      Founded
      -
      Hutchmed (china) Limited is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HCM. The last closing price for Hutchmed (china) was 249p. Over the last year, Hutchmed (china) shares have traded in a share price range of 190.40p to 353.00p.

      Hutchmed (china) currently has 871,601,095 shares outstanding. The market capitalization of Hutchmed (china) is £2.17 billion.

      Ask ADVFN Intelligence (AI)

      HCM Latest News

      More News

      Hutchmed China disposes of 45% stake in Shanghai joint venture

      Hutchmed (China) Ltd on Thursday said it has agreed to divest a 45% stake in Shanghai Hutchison Pharmaceuticals Ltd t ...

      January 02 2025
      Alliance News

      Hutchmed (China) Limited China NDA Acceptance for ORPATHYS and TAGRISSO

      Hutchmed (China) Limited 02 January 2025   Press Release   HUTCHMED Announces NDA Acceptance in China with Priority Review Status for ORPATHYS® and TAGRISSO® Combination in Lung Cancer...

      January 02 2025
      RNS Non-Regulatory

      Hutchmed (China) Limited Overseas Regulatory Announcement

      Hutchmed (China) Limited 02 January 2025       Overseas Regulatory Announcement - Disposal Transaction     HUTCHMED (China) Limited ("HUTCHMED") notes the below text, which is from an...

      January 02 2025
      RNS Regulatory News

      Hutchmed (China) Limited US$608m Divestment of Non-Core Joint Venture

      Hutchmed (China) Limited 02 January 2025   HUTCHMED Announces US$608 million Divestment of Non-Core Joint Venture   - HUTCHMED continues to deliver on its strategy outlined in November 2022 to...

      January 02 2025
      RNS Regulatory News

      Hutchmed (China) Limited Appointment of Joint Corporate Broker

      Hutchmed (China) Limited 31 December 2024     Appointment of Cavendish as Joint Corporate Broker in London     Hong Kong, Shanghai & Florham Park, NJ - Tuesday, December 31, 2024: HUTCHMED...

      December 31 2024
      RNS Regulatory News

      Hutchmed (China) Limited Blocklisting Six Monthly Return

      Hutchmed (China) Limited 30 December 2024   Blocklisting Six Monthly Return   Hong Kong, Shanghai & Florham Park, NJ - Monday, December 30, 2024: HUTCHMED (China) Limited ("HUTCHMED" or...

      December 30 2024
      RNS Regulatory News

      IN BRIEF: Hutchmed to get Takeda milestone payment

      Ltd - Hong Kong-based biopharmaceutical firm - Is to receive a USD10 million milestone payment from partner Takeda Pha ...

      December 13 2024
      Alliance News

      Hutchmed (China) Limited HUTCHMED to Receive Milestone Payment from Takeda

      Hutchmed (China) Limited 13 December 2024   Press Release   HUTCHMED to Receive Milestone Payment from Takeda following First European Reimbursement for FRUZAQLA® (fruquintinib)   - US$10...

      December 13 2024
      RNS Non-Regulatory

      Hutchmed (China) Limited Breakthrough Therapy Designation in China

      Hutchmed (China) Limited 12 December 2024   Press Release   HUTCHMED Announces Breakthrough Therapy Designation in China for ORPATHYS® and TAGRISSO® Combination in Certain Lung Cancer Patients...

      December 12 2024
      RNS Non-Regulatory

      Hutchmed China injection approval could be a "paradigm shift"

      Hutchmed China Ltd on Tuesday reported it was granted conditional approval in China for an injection to treat endomet ...

      December 03 2024
      Alliance News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-4-1.5810276679825325923632177251.61314604DE
      420.8097165991924725922554585240.46244957DE
      12-71-22.187532033622563107276.14957296DE
      26-42-14.4329896907291336225103684290.22650974DE
      52-6-2.35294117647255353190.486151284.29673778DE
      156-245.5-49.646107179494.549513097980249.59165634DE
      260-141-36.1538461538390656130101105347.01890161DE

      HCM - Frequently Asked Questions (FAQ)

      What is the current Hutchmed (china) share price?
      The current share price of Hutchmed (china) is 249.00p
      How many Hutchmed (china) shares are in issue?
      Hutchmed (china) has 871,601,095 shares in issue
      What is the market cap of Hutchmed (china)?
      The market capitalisation of Hutchmed (china) is GBP 2.17B
      What is the 1 year trading range for Hutchmed (china) share price?
      Hutchmed (china) has traded in the range of 190.40p to 353.00p during the past year
      What is the reporting currency for Hutchmed (china)?
      Hutchmed (china) reports financial results in USD
      What is the latest annual turnover for Hutchmed (china)?
      The latest annual turnover of Hutchmed (china) is USD 838M
      What is the latest annual profit for Hutchmed (china)?
      The latest annual profit of Hutchmed (china) is USD 100.78M
      What is the registered address of Hutchmed (china)?
      The registered address for Hutchmed (china) is PO BOX 309, UGLAND HOUSE, GRAND CAYMAN, KY1 1104
      What is the Hutchmed (china) website address?
      The website address for Hutchmed (china) is www.hutch-med.com
      Which industry sector does Hutchmed (china) operate in?
      Hutchmed (china) operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      0A2IH World Group Ltd
      $ 0.00
      (0.00%)
      		0
      0A2DCrh Plc
      $ 0.00
      (0.00%)
      		0
      0A2BBanco Bilbao Vizcaya Argentaria Sa
      $ 0.00
      (0.00%)
      		0
      0A22Anheuser Busch Inbev Nv
      $ 0.00
      (0.00%)
      		0
      0A1UUber Technologies Inc
      $ 66.00
      (0.00%)
      		1.65k
      0A2IH World Group Ltd
      $ 0.00
      (0.00%)
      		0
      0A2DCrh Plc
      $ 0.00
      (0.00%)
      		0
      0A2BBanco Bilbao Vizcaya Argentaria Sa
      $ 0.00
      (0.00%)
      		0
      0A22Anheuser Busch Inbev Nv
      $ 0.00
      (0.00%)
      		0
      0A1UUber Technologies Inc
      $ 66.00
      (0.00%)
      		1.65k
      0R0XTesla Inc
      $ 388.20
      (0.00%)
      		4.74k
      0JOQJd.com Inc
      $ 72.00
      (0.00%)
      		3.03k
      0HCIAlibaba Group Holding Ltd
      $ 81.10
      (0.00%)
      		2.3k
      0R1OAmazon.com Inc
      $ 217.50
      (0.00%)
      		1.67k
      0P4FFord Motor Co
      $ 9.665
      (0.00%)
      		1.67k

      Discussion

      View Full Feed
      sunspotter sunspotter 14 minutes ago
      Glenn Miller’s still missing, and Emil Malak and Rich Inza are still crooks.
      VPLM
      Flobewan Flobewan 25 minutes ago
      Marc loved your ides
      tinojax tinojax 26 minutes ago
      I usually enjoy a beer with my pizza...........I would like to know what's in the Kool Aid........
      PLUG
      mrfence mrfence 29 minutes ago
      Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
      [yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
      FMCC FNMA
      IVRT IVRT 45 minutes ago
      In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
      BMXI
      DewDiligence DewDiligence 45 minutes ago
      GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

      https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

      ENTA
      DewDiligence DewDiligence 46 minutes ago
      GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

      https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

      Guido2 Guido2 47 minutes ago
      This is DUE DILIGENCE! Thank you Free Fannie.

      https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
      FNMA
      StockItOut StockItOut 53 minutes ago
      That Xeriant PR excellently written with bullshit:

      ""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

      "the Company used the data to make several key
      XERI
      gitreal gitreal 56 minutes ago
      You were actually partially right....BMXI has filed some SEC documents, some necessary (Form 1-A), some unnecessary (Form 4). And they do summarize a lot of the stuff that I think are fabrications....their production, mining operations, etc. Time will tell, but I think a lot of it (and probably
      BMXI
      RichieBoy RichieBoy 1 hour ago
      Jim wrote a blurb about seeking more US business.

      Help you out any? 🤨
      AFFU
      DesktopDR DesktopDR 1 hour ago
      Any news or updates?
      VPLM
      Tahoe2468 Tahoe2468 1 hour ago
      .0915 by Thursday....... 
      KRTL
      skitahoe skitahoe 1 hour ago
      Remember GBM was redefined during the trial, thus some who were treated then had other forms of brain cancer. I believe the least we'll see in our label is brain cancer. Certainly GBM may be the deadliest of them, but treatment should work in all of them.

      According to Google, GBM ha
      NWBO
      fuagf fuagf 1 hour ago
      You are right about the crafty, evil, smart. Authoritarian methods have been in full view
      in capturing America. While we work to do the right things they plot to capture the lot.
      facts_matter14 facts_matter14 1 hour ago
      If there weren’t suckers born every minute, there wouldn’t be POSRMX bag holders down as much as 99%, and there sure as hell wouldn’t be anybody believing there is a pipeline of products.






      .
      SRMX
      StockItOut StockItOut 1 hour ago
      Your "closer" keeps getting extended. Then again extended. Then again extended. -- Consider that end. Now expired, horizon end now reached, and the view clarifies and we see it to be your desperation from years ago ongoing still, to pump this at any expense, where you attempt to instill FOMO to hold
      XERI
      fuagf fuagf 1 hour ago
      He would smother any question with words.
      Shawonsarker84 Shawonsarker84 1 hour ago
      $HMBL Sorry HMBL investors. XTIA now broke the record 2.7B share volume traded before the reverse split.



      https://x.com/shawonsarker84/status/1878696680088019193?t=rZlhkn2Jos4vWKxxQgXGfA&s=19
      HMBL XTIA
      chen1992 chen1992 1 hour ago
      https://www.energy.senate.gov/hearings/2025/1/hearing-to-consider-the-nomination-of-mr-chris-wright-to-be-secretary-of-energy

      https://www.commerce.senate.gov/2025/1/full-committee-nomination-hearing_2#:~:text=U.S.%20Senator%20Ted%20Cruz%20(R,Wednesday%2C%20January%2015%2C%20
      TGLO
      FNM500K FNM500K 1 hour ago
      Oh noooooo.....
      FNMA
      StockItOut StockItOut 1 hour ago
      OTC filings and attorney statements. my error.

      Point that it is on you to prove your claim, that:
      "There's no contract employees. There's no production shafts."

      Likewise for the company to do so, as we wait for an audit, apparently indefinitely.

      I
      BMXI
      Money4Nothing-M4N Money4Nothing-M4N 2 hours ago
      Definitely excited to hear about batch 5. I believe we should hear news very soon. if they began batch 5 immediately after batch 4 then 5 is overdue.

      And in light of last week's PR about Darwin's Bark Dragline silk, I'm expecting KBLB to have the attention of the DOD once again.
      KBLB
      rx7171 rx7171 2 hours ago
      Too bad no mention of the degree of brain atrophy of the Blar treated patients reverting to close to normal aging compared to the MAB treated patients having accelerated rate of atrophy.

      To me this is a bio marker that sets the two therapies at extreme ends of the plus minus continuum
      AVXL

      Your Recent History

      LSE
      HCM
      Hutchmed (china)
      AQSE
      ZGLD.GB
      ZKB Gold ETF AA CHF ETF
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads